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Abstract
To describe recent trends in prevalence of pre-existing diabetes mellitus (PDM) (i.e., type 1 or 
type 2 diabetes) and gestational diabetes mellitus (GDM) among delivery hospitalizations in the 
United States. Data on delivery hospitalizations from 1993 through 2009 were obtained from the 
Health Care Cost and Utilization Project (HCUP) Nationwide Inpatient Sample. Diagnosis-
Related Group codes were used to identify deliveries and diagnosis codes on presence of diabetes. 
Rates of hospitalizations with diabetes were calculated per 100 deliveries by type of diabetes, 
hospital geographic region, patient’s age, degree of urbanicity of patient’s residence, categorized 
median household income for patient’s ZIP Code, expected primary payer, and type of delivery. 
From 1993 to 2009, age-standardized prevalence of diabetes per 100 deliveries increased from 
0.62 to 0.90 for PDM (trend p < 0.001) and from 3.09 to 5.57 for GDM (trend p < 0.001). In 2009, 
correlates of PDM at delivery included older age [40–44 vs. 15–24: odds ratio 6.45 (95 % CI 
5.27–7.88)], Medicaid/Medicare versus private payment sources [1.77 (95 % CI 1.59–1.98)], 
patient’s ZIP Code with a median household income in bottom quartile versus other quartiles [1.54 
(95 % CI 1.41, 1.69)], and C-section versus vaginal delivery [3.36 (95 % CI 3.10–3.64)]. 
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Correlates of GDM at delivery were similar. Among U.S. delivery hospitalizations, the prevalence 
of diabetes is increasing. In 2009, the prevalence of diabetes was higher among women in older 
age groups, living in ZIP codes with lower household incomes, or with public insurance.
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Introduction
According to data from the U.S. National Health Interview Survey, the annual incidence of 
diagnosed diabetes among women of childbearing potential (i.e., 18–44 years) increased 
from 2.2 to 3.9 per 1,000 between 1997 and 2009 [1]. Increase in incidence is of public 
health concern because women with diabetes who become pregnant are at increased risk for 
a spectrum of serious complications for themselves and their offspring. Pregnancies among 
women with preexisting diabetes mellitus (PDM) (i.e., either type 1 or type 2 diabetes) are at 
increased risk for pregnancy-related hypertension, stillbirth, birth defects and preterm birth. 
Pregnancies complicated by gestational diabetes mellitus (GDM) are at increased risk for 
pre-eclampsia, macrosomia, birth trauma, hypoglycemia and jaundice [2–6]. Given the 
potential significant morbidity from diabetes in pregnancy, it becomes important to assess 
the extent to which the recent increase in incidence of diabetes among women of 
childbearing potential is manifesting as an increase in prevalence of diabetes in pregnancy in 
the United States.
Prior to 2000, published reports on trends in prevalence of diabetes in pregnancy were few 
and limited by the quality of information on diabetes available from existing data sources 
(i.e., birth certificates and surveys of maternal reports) and by the lack of representativeness 
of the populations surveyed [7, 8]. A recent report based on a national administrative 
database, namely, Research and Quality’s Healthcare Cost and Utilization Project [AHRQ 
HCUP] Nationwide Inpatient Sample [NIS], showing increases in the rates of hospital stays 
for GDM and PDM complicating pregnancy [9], suggest that this national database maybe 
useful for assessing population-based trends in diabetes in pregnancy in the United States.
In this study, we use data from NIS to describe trends in national prevalence of PDM and 
GDM in delivery hospitalizations for women 15–44 years of age, from 1993 through 2009. 
We also examine possible associations of national prevalence of PDM and GDM in delivery 
hospitalizations in 2009 with maternal age, urbanicity of county of residence, primary payer, 
and median household income of ZIP Code of residence.
Methods
Data Source
We used NIS data to identify hospital discharges, and procedures for deliveries involving 
diabetes diagnosed prior to and during pregnancy. The NIS contains information on hospital 
inpatient stays from states participating in HCUP, a federal-state data collection partnership 
[10]. Annual data collection by HCUP includes all community hospitals from participating 
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states stratified by rural/urban location, number of beds, geographic region, teaching status, 
and hospital ownership. Within each stratum, a systematic random 20 % sample of 
approximately 1,000 hospitals is drawn each year. The NIS includes all hospital discharges 
in sampled hospitals and is designed to produce national estimates of inpatient care. Our 
analysis included annual NIS data from 1993 through 2009, years for which the HCUP NIS 
data are available, reliable, and recommended for trend analysis [11]. This research was 
conducted according to prevailing ethical principles. This study was reviewed by the Human 
Subjects Coordinator at the Centers for Disease Control and Prevention and, as an analysis 
of secondary data without identifiers, was determined not to require Institutional Review 
Board review.
Definition and Identification of Delivery Discharges (Denominator)
Hospital delivery discharges were identified using Diagnosis-Related Group (DRG) codes. 
DRG codes comprise a patient classification system that categorizes hospital stays into 
groups that are clinically homogeneous with respect to resource use, including diagnosis and 
type of treatment/procedure. Each hospital stay has one DRG assigned to it. Delivery stays 
were identified by discharges having a DRG code of 767–768 and 774–775 (vaginal 
delivery) or 765–766 (C-section) during 2008–2009 or a DRG code 372–375 (vaginal 
delivery) or 370–371 (C-section) [12] for the period 1993–2007.
Definition and Identification of Diabetes in Pregnancy Discharges (Numerator)
We identified deliveries with a PDM diagnosis by the presence of International 
Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis 
codes 648.0× listed anywhere on the discharge record and a GDM diagnosis by the presence 
of ICD-9-CM codes 648.8× listed anywhere on the discharge record. For the few cases that 
listed both codes, cases were counted as PDM because 648.0× specifically excludes 
gestational diabetes.
Definition of Covariates
Variables examined include delivery year, geographic location of the hospital, patient’s age, 
patient’s county of residence classified into rural/urban categories, median household 
income of residential ZIP Code for the patient, expected primary payer (i.e., insurance 
status), and type of delivery, U.S. Census region where the delivery hospital was located 
was categorized as: Northeast, Midwest, South, and West. Age was categorized as 15–19, 
20–24, 25–29, 30–34, 35–39, and 40–44 years. The degree of urbanicity of the patient’s 
county of residence was categorized as: [1] large metropolitan area with at least one million 
residents (Central); [2] small metropolitan areas with 50,000 to less than one million 
residents (Small metro); [3] micropolitan areas with 10,000 to less than 50,000 (Fringe); and 
[4] not metropolitan or micropolitan (that is, less than 10,000 residents (Rural)). Health 
insurance status at the time of the hospital discharge was classified according to the type of 
expected primary payer: private, Medicare/Medicaid, uninsured (i.e., no charge and self-
pay), and public insurance other than Medicare/Medicaid (i.e., Worker’s Compensation, 
Civilian Health and Medical Program of the Uniformed Services, Civilian Health and 
Medical Program of the Department of Veterans Affairs, Title V, and other government 
programs). Categories of median household income for ZIP Codes of patient’s residence 
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were created by classifying ZIP Codes based on 2008 median annual household income 
quartiles (1 = $1 to $38,999; 2 = $39,000–$48,999; 3 = $49,000–63,999; and 4 ≥ $64,000) 
for the purpose of comparing ZIP codes with median household income of < $39,000 versus 
everyone else. Type of delivery was categorized as C-section and vaginal based on the 
DRGs [12]. Because information on race/ethnicity was not collected systematically among 
all states for the study period, we did not examine prevalence variation by race/ethnicity.
Statistical Methods
We estimated age-specific and age-standardized prevalence of PDM and GDM. The 
population from the Census 2000 Summary File was used for age standardization to 
examine the trends in prevalence. We used Joinpoint software [13] to evaluate trends in 
prevalence for PDM and GDM. Details for Joinpoint regression analysis have been 
previously published [14]. We used SUDAAN 11.0.0 (Research Triangle Institute, Research 
Triangle Park, NC) to account for the sampling design in our estimation of prevalence of 
each type of diabetes [11]. We used Chi square statistics to test for trends in prevalence and 
compare frequency distributions of categorical variables between groups, and logistic 
regression to examine possible associations of diabetes with age group, type of delivery, ZIP 
Code median household income, location of hospital, and expected primary payer.
Results
From 1993 through 2009, the age-standardized prevalence of diabetes per 100 deliveries 
increased from 0.62 to 0.90 for PDM (trend test, i.e., average annual percent change is 
different from zero, p < 0.001) (Fig. 1a) and from 3.09 to 5.57 for GDM (trend test, i.e., 
average annual percent change is different from zero, p < 0.001) (Fig. 1b). The average 
annual percent change in age-standardized prevalence per 100 deliveries was 3.6 % (95 % 
CI 3.0–4.2 %) for PDM and 4.4 % (95 % CI 3.9–4.8 %) for GDM.
Between 1993 and 2009, the increase in prevalence of PDM and GDM over time was 
evident in all age groups. The increase in prevalence of PDM was greatest for the 40–44 
years of age group (from 1.60 to 2.04 %) and lowest for the 15–19 years of age group (from 
0.25 to 0.32 %) (Fig. 2a). Similarly, the increase in prevalence of GDM by age group was 
greatest for the 35–39 years of age group (from 5.91 to 10.07 %) and lowest for the 15–19 
years of age group (from 0.83 to 1.46 %) (Fig. 2b).
In 2009, the NIS data included 4.1 million hospital deliveries among women 15–44 years of 
age, of which 264,939 were complicated by any diabetes, 36,851 (13.9 %) by PDM, and 
228,088 (86.1 %) by GDM (Table 1). Deliveries complicated by PDM and GDM were more 
likely than deliveries not complicated by diabetes to be among older age women and to be 
delivered by C-section than by vaginal delivery. The overall prevalence of diabetes per 100 
deliveries in 2009 was 6.47 % for any type of diabetes, 0.90 % for PDM, and 5.57 % for 
GDM.
The prevalence of diabetes increased with maternal age (Table 2). The age-standardized 
prevalence per 100 delivery hospitalizations was greater for GDM than for PDM. The 
prevalence of PDM was higher among patients located in rural areas than among other areas, 
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whereas GDM prevalence was higher among patients living in central counties of metro 
areas with populations of 1 million or greater. The prevalence of PDM was higher among 
deliveries where the expected primary payer was Medicaid/Medicare than among deliveries 
where the expected primary payer was private insurance, while the opposite was true for the 
prevalence of GDM. For both PDM and GDM, prevalence was higher among patients 
residing in ZIP Codes where the median household income was in the bottom quartile and 
among C-section than among vaginal deliveries.
In 2009, the odds of PDM at delivery increased monotonically with maternal age (Table 3). 
The odds of PDM deliveries were higher in the South (odds ratio (OR) 1.45; 95 % CI 1.14, 
1.84) than in the Northeast; among deliveries where an expected primary payer was 
Medicaid/Medicare (OR 1.77; 95 % CI 1.59, 1.98) or Other public insurance (OR 1.29; 95 
% CI 1.01, 1.65) versus private insurance; and in patients who resided in ZIP Codes where 
the median household income was in the lowest quartile (OR 1.54; 95 % CI 1.41, 1.69) 
versus higher income areas. The odds of a GDM delivery showed a steeper increase with 
maternal age and were higher among deliveries to women whose primary payer was 
Medicaid/Medicare (OR 1.30; 95 % CI 1.21, 1.41) or Uninsured (OR 1.34; 95 % CI 1.08, 
1.66) versus private insurance, and in patients residing in ZIP Codes where the median 
household income was less than $39,000 (OR 1.08; 95 % CI 1.00, 1.16) versus at least 
$39,000. The odds of a C-section delivery versus a vaginal delivery were greater for all 
deliveries complicated by diabetes, but were greater for PDM (OR 3.36; 95 % CI 3.10, 3.64) 
than for GDM (OR 1.56; 95 % CI 1.51, 1.61).
Conclusions
Our findings of increasing trends in prevalence rates of PDM and GDM among delivery 
hospitalizations based on HCUP NIS data are consistent with and expand on two previous 
reports based on similar national data through 2004 and 2008 [9, 15], respectively; our 
findings indicate that such trends continued through 2009. Because the information provided 
by ICD-9-CM codes for classifying pregnancies complicated by PDM is not adequate for a 
reliable differentiation of PDM types (i.e., type 1 vs. type 2 diabetes), we were not able to 
derive and evaluate trends in prevalence and correlates of PDM delivery hospitalizations by 
type of PDM.
Our observations on the correlations of prevalence of diabetes in pregnancy with maternal 
age, type of expected payer and type of delivery are also consistent with previous 
observations [9, 16]. The observed positive correlation between older maternal age and 
prevalence of diabetes in pregnancy may explain in part the increasing temporal trends in 
pregnancies complicated by diabetes as there has been an increasing proportion of 
pregnancies among women in older age groups in the U.S. in recent decades. However, 
given the increases in prevalence of diabetes in pregnancy evident for all maternal age 
groups, other factors may have contributed to such trends, including increased levels of 
screening and diagnosis of diabetes in pregnancy and increased prevalence of vulnerable 
populations and/or risk factors for type 2 diabetes and GDM (e.g., obesity and physical 
inactivity). As the available NIS data did not include such information, we were not able to 
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examine the contributions of these factors to the variation in prevalence of diabetes in 
pregnancy.
Our findings of correlations of prevalence of diabetes complicating pregnancy among 
deliveries to women with residence in ZIP codes with a low median household income (i.e., 
< $39,000) are of interest. We are not aware of previous reports of such associations, but our 
findings are not unexpected. A higher prevalence of diabetes has been noted among women 
of some minority groups or whose expected primary payer is Medicaid/Medicare [15, 17], 
either of whom may be disproportionately represented in ZIP codes with a low median 
household income. Our findings, however, do identify a subgroup of women who would 
benefit from targeted screening and prevention interventions for type 2 diabetes.
The higher rates of C-section versus vaginal deliveries associations complicated by PDM or 
GDM are not unexpected as diabetes complicating a pregnancy is an indication for C-section 
delivery. However, such increasing trends in delivery hospitalizations complicated by 
diabetes are of concern as they may have contributed to an increasing trend in the number of 
C-section deliveries [18], and concomitant morbidity [19].
Our findings also suggest that HCUP NIS data on discharge deliveries offer several 
advantages for surveillance of diabetes in pregnancy compared to data from other sources 
such as records of birth certificates or surveys of women of childbearing potential. Birth 
certificate records are available for public use; however, such records exclude delivery 
hospitalizations that result in stillbirths and are limited by the quality of information on 
history of maternal diabetes. Surveys of women such as CDC’s Pregnancy Risk Assessment 
Monitoring System (PRAMS) [20] are also available for public use but are limited as a data 
source for surveillance of diabetes in pregnancy because of the year-to-year variation in 
participation rates among women surveyed in previous years and limited quality of 
information on diabetes status in pregnancy derived from self-reports [21]. In contrast, NIS 
data on discharge deliveries come from large national probability samples of all delivery 
hospitalizations regardless of outcomes, are collected on an ongoing basis using standard 
procedures over time, with extensive documentation, and are available for public use. 
Inclusion of DRG and ICD9-CM diagnosis codes in the NIS database allows for 
identification of delivery hospitalizations and determination of which deliveries are 
complicated by PDM or GDM more accurately and consistently over time and across 
regions of the US than birth certificate records and surveys of women of childbearing age.
One potential limitation of NIS data for monitoring of prevalence of diabetes in pregnancy 
over time is the absence of data concerning deliveries that occur outside hospitals. However, 
because such deliveries are estimated to account for < 1 % of all deliveries [22], their 
exclusion from the NIS data is not likely to affect materially inferences of trends in 
prevalence of diabetes in pregnancy over time or of possible of variations in such prevalence 
with maternal characteristics. The NIS data do not include information on the extent to 
which deliveries captured in the NIS undergo screening for diabetes before or early in 
pregnancy. Therefore, we could not account for under-ascertainment of cases of diabetes in 
pregnancy so our estimates of prevalence of diabetes in pregnancy probably represent 
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underestimates and our estimates of odds ratios with possible correlates of diabetes in 
pregnancy may be attenuated.
Surveillance of diabetes in the general population has been an important tool for assessing 
the burden of diabetes in the general population over time, identifying high risk or 
vulnerable groups in the population, and evaluating the impact of community interventions. 
Because women with diabetes who become pregnant and their offspring are at risk for a 
spectrum of serious but preventable complications, implementing a population-based 
surveillance system for monitoring diabetes in pregnancy can be useful in evaluating 
progress in prevention efforts at the population level. The representativeness and standard 
methodology of NIS data would seem to make such data the most practical and reliable data 
source for monitoring temporal trends in diabetes in pregnancy in the United States today.
Our findings contribute to the limited body of literature on the burden of diabetes in 
pregnancy in several respects. First, our findings corroborate the increasing trends in the 
population-based prevalence of both PDM and GDM noted previously [9, 15, 17], and 
indicate that these trends have continued through 2009, the most recent year for which NIS 
data were available. These trends highlight that diabetes in pregnancy remains a public 
health issue in need of ongoing monitoring, attention and more concerted prevention efforts. 
Second, our findings identify a subgroup of delivery hospitalizations among women who are 
older or with public insurance or no insurance as having a higher prevalence of diabetes in 
pregnancy and for whom screening and targeted prevention efforts need to be developed, 
implemented and monitored for effectiveness. Third, our findings illustrate that NIS data 
represent a reliable and practical data source for ongoing monitoring of pregnancies 
complicated by diabetes.
Our findings have implications for the prevention of type 2 diabetes among women of 
childbearing age and diabetes-related pregnancy complications. First, because women with 
GDM are at high risk for developing type 2 diabetes and effective lifestyle interventions are 
available to reduce their risk [23, 24], it becomes important to ensure that women with a 
history of GDM have follow-up screening for type 2 diabetes and are referred to a network 
of sites that can provide intervention services to such women. Second, for women of 
childbearing age with a history of type 2 diabetes, optimal management of their diabetes will 
require that they be empowered to receive preconception counseling and care [25]. Third, 
for women of childbearing age considered at risk of type 2 diabetes for other reasons (i.e., 
family history of diabetes, impaired fasting glucose, older age, or overweight status) and 
who are planning to become pregnant, it becomes important to provide access to 
preconception care capable of screening for and managing diabetes.
In summary, our findings show that among U.S. delivery hospitalizations, the prevalence of 
diabetes increased between 1993 and 2009, an observation that is consistent with previous 
reports of increases in prevalence of diabetes among women of childbearing age in general 
and of diabetes in pregnancy in particular. In addition, our findings on the prevalence of 
diabetes among delivery hospitalizations in 2009 identified subgroups of women for whom 
delivery hospitalization had a higher prevalence of diabetes and who would benefit from 
targeted prevention interventions, namely: women of childbearing age in older age groups, 
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whose expected primary payer was public, or whose residence was in ZIP codes with low 
median household income. Lastly, our findings indicate that NIS data are a useful and a 
practical data source for population-based monitoring of trends in prevalence of diabetes in 
pregnancy and as a means for identifying subgroups of women of childbearing age at risk 
for diabetes for targeted screening and prevention interventions.
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a Annual age-standardized Prevalence of PDM per 100 delivery hospitalizations, women 
15–44 years, HCUP NIS. b Annual age-standardized Prevalence of GDM per 100 Delivery 
Hospitalizations, Women 15–44 years, HCUP NIS
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a Annual prevalence of PDM per 100 delivery hospitalizations, women 15–44 years, HCUP 
NIS. b Annual prevalence of GDM per 100 delivery hospitalizations, women 15–44 years, 
HCUP NIS
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Table 2
Prevalence for hospital deliveries with diabetes (per 100 deliveries), by maternal age, urban/rural location of 
hospital, expected primary payer, median household income of patient’s ZIP Code, and type of delivery, 
United States, Healthcare Cost and Utilization Project Nationwide Inpatient Sample, 2009
Any diabetes
Prevalencea (95 % CIb)
Pre-existing diabetes
Prevalence (95 % CI)
Gestational diabetes
Prevalence (95 % CI)
Overall 6.47 (6.17, 6.77) 0.90 (0.83, 0.98) 5.57 (5.31, 5.84)
U.S. Census region in which hospital is located
  Northeast 6.13 (5.55, 6.76) 0.73 (0.62, 0.86) 5.40 (4.85, 6.00)
  Midwest 6.26 (5.53, 7.09) 0.79 (0.66, 0.95) 5.47 (4.81, 6.23)
  South 6.58 (6.10, 7.10) 1.04 (0.92, 1.19) 5.53 (5.13, 5.97)
  West 6.71 (6.23, 7.22) 0.88 (0.75, 1.04) 5.82 (5.40, 6.28)
Age group
  15–19 years 1.78 (1.65, 1.93) 0.32 (0.28, 0.38) 1.46 (1.35, 1.58)
  20–24 3.54 (3.38, 3.71) 0.55 (0.49, 0.61) 2.99 (2.85, 3.14)
  25–29 5.96 (5.69, 6.23) 0.81 (0.74, 0.89) 5.14 (4.91, 5.38)
  30–34 8.50 (8.03, 9.00) 1.13 (1.03, 1.25) 7.37 (6.96, 7.80)
  35–39 11.67 (10.90, 12.49) 1.60 (1.42, 1.80) 10.07 (9.43, 10.76)
  40–44 15.47 (14.43, 16.58) 2.04 (1.76, 2.38) 13.43 (12.53, 14.39)
Patient’s county of residence
  Central 6.72 (6.05, 7.46) 0.93 (0.79, 1.08) 5.80 (5.21, 6.44)
  Fringe 6.20 (5.86, 6.55) 0.75 (0.67, 0.83) 5.45 (5.14, 5.79)
  Small metro 6.66 (6.26, 7.09) 0.99 (0.88, 1.10) 5.68 (5.33, 6.04)
  Rural 6.24 (5.93, 6.57) 1.07 (0.96, 1.20) 5.17 (4.91, 5.45)
Primary payer
  Private 5.84 (5.56, 6.13) 0.73 (0.68, 0.79) 5.11 (4.85, 5.38)
  Medicaid/Medicare 7.78 (7.37, 8.22) 1.26 (1.14, 1.40) 6.52 (6.17, 6.89)
  Uninsured 7.31 (6.09, 8.77) 0.79 (0.61, 1.01) 6.53 (5.40, 7.88)
  Other public insurance 5.90 (5.24, 6.63) 0.89 (0.70, 1.13) 5.01 (4.47, 5.61)
Median household income of patient’s ZIP Code
  ≥ $39,000 6.25 (5.96, 6.55) 0.80 (0.74, 0.88) 5.45 (5.19, 5.72)
  < $39,000 (lowest quartile) 7.18 (6.71, 7.69) 1.26 (1.15, 1.37) 5.92 (5.51, 6.36)
Type of delivery
  Vaginal 5.21 (4.92, 5.52) 0.50 (0.44, 0.56) 4.71 (4.46, 4.99)
  C-section 8.81 (8.46, 9.17) 1.65 (1.52, 1.80) 7.16 (6.87, 7.46)
a
Prevalence data are age-standardized to the 2009 population of deliveries
b
CI Confidence Interval
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Table 3
Adjusted odds ratios and 95 % confidence intervals (CI) for hospital deliveries complicated by diabetes and 
maternal age, hospital location, primary expected payer, median household income of patient’s ZIP Code, and 







U.S. Census region in which hospital is located
  Northeast 1.00 (reference) 1.00 (reference)
  Midwest 1.09 (0.83, 1.44) 1.02 (0.85, 1.22)
  South 1.45 (1.14, 1.84)1 1.03 (0.89, 1.19)
  West 1.23 (0.96, 1.58) 1.09 (0.95, 1.26)
Age group
  15–19 years 1.00 (reference) 1.00 (reference)
  20–24 1.71 (1.50, 1.95)1 2.08 (1.95, 2.22)1
  25–29 2.54 (2.20, 2.92)1 3.66 (3.40, 3.93)1
  30–34 3.54 (3.05, 4.12)1 5.37 (4.94, 5.83)1
  35–39 5.01 (4.22, 5.95)1 7.56 (6.90, 8.28)1
  40–44 6.45 (5.27, 7.88)1 10.46 (9.48, 11.55)1
Patient’s county of residence
  Central 1.00 (reference) 1.00 (reference)
  Fringe 0.80 (0.68, 0.94) 0.93 (0.83, 1.05)
  Small metro 1.06 (0.87, 1.29) 0.98 (0.86, 1.11)
  Rural 1.14 (0.95, 1.36) 0.88 (0.78, 1.00)
Primary payer
  Private 1.00 (reference) 1.00 (reference)
  Medicaid/Medicare 1.77 (1.59, 1.98)1 1.30 (1.21,1.41)1
Uninsured 1.13 (0.87, 1.47) 1.34 (1.08, 1.66)1
Other public insurance 1.29 (1.01, 1.65)1 1.00 (0.88,1.14)
Median household income of patient’s ZIP Code
  ≥ $39,000 1.00 (reference) 1.00 (reference)
  < $39,000 1.54 (1.41, 1.69)1 1.08 (1.00, 1.16)2
Type of delivery
  Vaginal 1.00 (reference) 1.00 (reference)
  C-section 3.36 (3.10, 3.64)1 1.56 (1.51, 1.61)1
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